How Cannabis Can Act As a Reverse “Gateway Drug” | Dr. Zach Walsh

"Isn't microdosing just placebo effect??" You may have heard this before but is it true?

Dr. Zachary Walsh, a leading clinical psychologist and researcher, explores the therapeutic potential of psychedelics in this episode, focusing on psilocybin-assisted psychotherapy for opioid titration and his involvement in the Microdose.me study.

He explains the distinction between cannabis, used for symptom relief, and psychedelics and discusses the controversial link between cannabis and psychosis, emphasizing the need for further research.

Join us as he shares insights on the evolving role of clinicians in supporting patients interested in microdosing and the challenges of integrating psychedelic medicine into healthcare!

Donate to MAPS Canada at https://mapscanada.org/donate/